LuMind RDS Research Partner Jamie Edgin Wins $2.9 Million Grant

Categories: Blog, Clinical Trials, Ds / Alzheimer's Connection, Ds Research, Meet Our Friends, News, Other, Why Support Research?
This holiday season, LuMind Research Down Syndrome is celebrating Dr. Jamie Edgin and her newly awarded five-year, $2.9 million grant from the National Institute of Child Health and Development (NICHD) to expand research on developing the Arizona Cognitive Testing Battery. Dr. Jamie Edgin is an assistant professor of psychology and serves as the associate head …

Read More

Statement from LuMind Research Down Syndrome Foundation on the Roche Clinical Trials

Categories: Blog, Clinical Trials, Ds Research, News
From LuMind RDS Board Chairman, Ryan Hartman We thank you for turning to LuMind Research Down Syndrome with your questions and comments about the news of the Roche CLEMATIS Phase 2 clinical trial for RG1662/Basmisanil. As the largest source of private funding for Down syndrome cognition research, we are in contact with many people from our …

Read More

Clinical Trial Update: Green Tea’s Effect on Boosting Cognition

Categories: Blog, Clinical Trials, Ds Research, News
News from the phase 2 clinical trial of with a chemical in green tea has been shown to improve cognitive ability in people with Down syndrome, according to researchers from the Centre for Genomic Regulation in Barcelona. The study will be published in The Lancet Neurology, but there are news reports outlining the preliminary results of this interesting …

Read More

Ground-breaking New Scientific Publication on anti-Abeta Vaccine in Preclinical Model of Down Syndrome

Categories: Blog, Clinical Trials, Ds Research, News
By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer AC Immune announced the publication of a ground-breaking scientific study on an anti-A-beta vaccine potentially signaling a way to treat cognitive deficits in people with Down syndrome (Ds). The study, entitled An anti-Abeta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome, was …

Read More